• Keppel Offshore & Marine Ltd in an internal investigation and coordinated resolutions with the U.S., Brazilian, and Singaporean criminal authorities in relation to corrupt payments to Petrobras and other Brazilian officials.
    • A former senior executive of a global healthcare company in a DOJ/SEC investigation of potential accounting and FCPA issues.
    • A leading financial services company in a formal investigation launched by the Department of Justice into the potential corruption of foreign officials, Libyan sovereign investors and equity derivatives business.
    • A former executive of a leading financial services company in an SEC investigation of potential FCPA issues involving hiring practices in Asia.
    • Multiple individuals at various financial institutions in DOJ and CFTC investigations relating to foreign exchange trading practices.
    • A hedge fund founder in DOJ and SEC investigations of potential insider trading.
    • A former government official of an African nation in FCPA and money laundering charges in the Southern District of New York.
    • A Fortune 100 company in civil and criminal investigations regarding possible FCPA violations, resulting in both the DOJ and SEC closing their investigations without bringing any charges or seeking any penalties.
    • A major investment bank in federal and state regulatory investigations relating to mortgage origination, underwriting and securitization practices.
    • Several foreign financial institutions in the DOJ Tax Division’s Program for Swiss Banks.
    • Multiple individuals in multi-jurisdictional investigations concerning foreign currency trading.
    • The former global head of structured-products ABS collateralized debt obligations at a major investment bank in an SEC inquiry into the offering of notes in a synthetic CDO.
    • A large pharmaceutical company in conducting internal investigations of alleged corruption at two European subsidiaries.
    • The audit committee of the board of directors of a multinational consulting firm as independent counsel in an internal investigation of potential FCPA violations relating to projects in the Middle East, Latin America and Asia.
    • A multinational consumer products company in an internal investigation regarding allegations of procurement and expense abuse fraud.
    • Bristol-Myers Squibb in defending against a $3.4 billion contract and tort claim by generic drug manufacturer Apotex, winning a unanimous jury verdict of no liability.
    • Siemens’s Audit Committee in a worldwide investigation into possible corrupt payments to government officials leading to an early settlement with the U.S. and German authorities.
    • A large pharmaceutical company in a grand jury investigation of antitrust and related criminal charges, as well as in securities class action litigation.
    • Several individuals in the SEC’s investigation of sales of CDOs backed by subprime mortgages.
    • Several individuals in stock options back-dating investigations conducted by the United States Attorney’s Office for the Eastern District of New York, the SEC, and the New York County District Attorney’s Office.


  • Stanford Law School, 1997, J.D.
  • Harvard University, 1994, M.P.P.
  • Columbia University, 1992, B.A.


  • English